Menu
Fechar
hrs4r
 I want to donate

IDIBGI's Respiratory Research Group is composed of several researchers from the Pneumology Department. It focuses on research into bronchiectasis, diffuse interstitial diseases, COVID19, sleep disorders, lung cancer and thromboembolic pulmonary hypertension.

The research is complemented by intense clinical activity, which has led the group to be invited to conferences in international congresses, to carrying out draft reviews and to publishing in high impact journals, as well as to being experts in the field of respiratory diseases, both nationally and internationally.

Main lines of research
  • Bronchiectasis: Etiology, diagnosis, and treatment
  • Sleep disorders: Diagnosis in primary medicine and vascular repercussions of the disease
  • Pulmonary hypertension
  • Early diagnosis of lung cancer
  • Occupational respiratory pathologies
  • Diffuse interstitial lung disease
Strategic objectives
  • Bronchiectasis: research into different aetiologies, including cystic fibrosis, bronchial infection and treatment.
  • Obstructive Sleep Apnoea Syndrome (OSAS): early diagnosis, diagnosis in the primary care setting, vascular complications; endothelial and metabolic dysfunction and identification of plasma and cellular biomarkers.
  • Diffuse interstitial and occupational diseases: silicosis in marble workers; asbestos-associated pathology.
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Research on new therapeutic targets, causes of the disease, vascular dysfunctions and in vitro 3D and in vivo models of endothelial pathology of CTEPH.
  • Lung Cancer: Detection of ctDNA as a diagnostic tool in lung cancer.
  • COVID-19: Advanced respiratory therapies in COVID-19 patients. Respiratory and vascular pulmonary sequelae in patients who have survived COVID-19.
Publications
Torrente-Nieto A, Rojas Calvera E, Haro-Estarriol M

Endoscopic Visualization of the Interior of a Cavitated Lung Lesion.

ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59, 50-50 dx.doi.org/10.1016/j.arbres.2022.07.015
Orriols R, Torrente A, Campà MT, Comas-Cufí M, Tura-Ceide O, Sabater G, Vendrell M

Artificial Stone Silicosis. Progression and Laboral Impact After 3-years Follow-up.

ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59, 267-269 dx.doi.org/10.1016/j.arbres.2022.11.008
Ayyoub S, Orriols R, Oliver E, Ceide OT

Thrombosis Models: An Overview of Common In Vivo and In Vitro Models of Thrombosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 dx.doi.org/10.3390/ijms24032569
Eichstaedt CA, Belge C, Chung WK, Gräf S, Grünig E, Montani D, Quarck R, Tenorio-Castano JA, Soubrier F, Trembath RC, Morrell NW

Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH.

EUROPEAN RESPIRATORY JOURNAL, 2023, 61 dx.doi.org/10.1183/13993003.01471-2022
Cabanillas Díez-Madroñero C, Briones Gómez A, Luna Pardo C

Spontaneous Bacterial Empyema Due to Enterococcus faecalis.

ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59, 113-113 dx.doi.org/10.1016/j.arbres.2022.08.013
Peinado VI, Guitart M, Blanco I, Tura-Ceide O, Paul T, Barberà JA, Barreiro E

Atrophy signaling pathways in respiratory and limb muscles of guinea pigs exposed to chronic cigarette smoke: role of soluble guanylate cyclase stimulation.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2023, 324, 677-693 dx.doi.org/10.1152/ajplung.00258.2022
Ayyoub S, Blanco I, Izquierdo-García JL, Tura-Ceide O

Editorial: Metabolic changes in vascular disorders: A path for early diagnosis and new therapeutic targets.

Frontiers In Cardiovascular Medicine, 2023, 10, 1163298-1163298 dx.doi.org/10.3389/fcvm.2023.1163298
Poyatos P, Gratacós M, Samuel K, Orriols R, Tura-Ceide O

Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension.

Antioxidants, 2023, 12 dx.doi.org/10.3390/antiox12051006
Blanco I, Marquina M, Tura-Ceide O, Ferrer E, Ramírez AM, Lopez-Meseguer M, Callejo M, Perez-Vizcaino F, Peinado VI, Barberà JA

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension.

FRONTIERS IN PHARMACOLOGY, 2023, 14, 1145994-1145994 dx.doi.org/10.3389/fphar.2023.1145994
Herrero-Cortina B, Lee AL, Oliveira A, O'Neill B, Jácome C, Dal Corso S, Poncin W, Muñoz G, Inal-Ince D, Alcaraz-Serrano V, Reychler G, Bellofiore A, Tonia T, Chalmers JD, Spinou A

European Respiratory Society statement on airway clearance techniques in adults with bronchiectasis.

EUROPEAN RESPIRATORY JOURNAL, 2023, 62 dx.doi.org/10.1183/13993003.02053-2022
Competitive projects
Respiratory

Diagnostic and treatment of Sleep Apnea Hypopnea Syndrome in Primary Care

Codi oficial: 210450 Start date:01/01/2022 Data fi: 31/12/2024 Investigador/a principal: OLGA TURA CEIDE, ANTON OBRADOR LAGARES Organisme finançador: EUROPEAN INSTITUTE OF TECHNOLOGY Ajuda: 130,956 €
Respiratory

Estudio del orígen y caracteristicas de la disfunción endotelial en la HPTEC y en la COVID-19 (SIENA).

Codi oficial: PI21/01212 Start date:01/01/2022 Data fi: 31/12/2024 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 129,470 €
Respiratory

Estudio del origen y características de la disfunción endotelial en la hipertensión pulmonar tromboembólica crónica (HPTEC)

Codi oficial: 2023_SEC_OTC Start date:16/06/2023 Data fi: 31/12/2027 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: SOCIEDAD ESPAÑOLA DE CARDIOLOGIA Ajuda: 15,000 €
Respiratory

Network For Research In Vascular Ageing

Codi oficial: CA18216 Start date:05/11/2019 Data fi: 04/11/2023 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY (COST) Ajuda: 0 €
Respiratory

Ajuda de personal FI - Sana Ayyoub

Codi oficial: 2022 FI_B 00941 Start date:01/06/2022 Data fi: 31/05/2025 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 69,143.51 €
Respiratory

Ayuda de Personal Miguel Servet II Olga Tura

Codi oficial: CPII22/00006 Start date:01/06/2023 Data fi: 31/05/2026 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 101,250 €
Respiratory

Ayuda de personal PFIS 2022 - Míriam Peracaula

Codi oficial: FI22/00133 Miriam Peracaula Start date:01/01/2023 Data fi: 31/12/2026 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 119,567 €
Transfer
Guies clíniques

- Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, Cantón R, Vendrell M, Polverino E, de Gracia J, Prados C. Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults. Arch Bronconeumol. 2018 Feb;54(2):79-87. doi: 10.1016/j.arbres.2017.07.015. Epub 2017 Nov 9. English, Spanish.

- Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, De Soyza A,, Hill AT, Haworth CS, Vendrell M, Ringshausen FC19, Subotic D20, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD. European Respiratory Society guidelines for the management of adult bronchiectasis. European Respiratory Journal. 2017 Sep 9;50(3)

- Grup de Treball de l’Asma Greu de la Comissió Farmacoterapèutica de l’Institut Català de la Salut. Guia de tractament de l’asma greu amb fàrmacs biològics. Barcelona: Institut Català de la Salut; 2021.

Job offers

Team

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

 menu